05/27/2026
This is a remarkable breakthrough, sharing to spread awareness :)
Japanese scientist Dr. Toru Miyazaki has developed a groundbreaking injectable treatment that could nearly double the average cat’s lifespan — from around 15 years to almost 30 years.
The therapy targets chronic kidney disease, the leading cause of death in cats, by delivering an activated form of a protein called AIM directly to the kidneys. This restores their natural waste-clearing function that cats are genetically unable to activate on their own.
Trials have shown remarkable results, with cats suffering from advanced kidney disease recovering after treatment. It works both as prevention and therapy.
Commercialization is expected to begin in Japan in 2025, with wider global availability by 2027. Researchers also believe this discovery could have important implications for human medicine.
Follow for more breakthroughs changing lives for animals and humans! 🐱❤️
